Clincosm LogoSign in Get a demo

Waldenstrom's Macroglobulinemia

Showing 1 - 25 of 44
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Waldenström's Macroglobulinemia Trial (zanubrutinib,bendamustine,rituximab)

Not yet recruiting
  • Waldenström's Macroglobulinemia
  • (no location specified)
Aug 4, 2023

Waldenstrom's Macroglobulinemia Trial in Houston (Bortezomib, Rituximab, Valacyclovir)

Active, not recruiting
Has Results
  • Waldenstrom's Macroglobulinemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 5, 2022

Waldenstrom's Macroglobulinemia Trial in Boston (Ibrutinib)

Completed
Has Results
  • Waldenstrom's Macroglobulinemia
  • Boston, Massachusetts
  • +1 more
Dec 5, 2022

Waldenström's Macroglobulinemia Trial in Worldwide (BGB-3111, Ibrutinib)

Completed
  • Waldenström's Macroglobulinemia
  • Phoenix, Arizona
  • +79 more
Jul 6, 2022

Waldenstrom's Macroglobulinemia Trial in Boston (Ulocuplumab, Ibrutinib)

Active, not recruiting
  • Waldenstrom's Macroglobulinemia
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jun 20, 2022

Waldenström's Macroglobulinemia Trial in Ulm (Dexamethasone, Rituximab, Cyclophosphamide, Dexamethasone, Rituximab,

Active, not recruiting
  • Waldenström's Macroglobulinemia
  • Dexamethasone, Rituximab, Cyclophosphamide
  • Dexamethasone, Rituximab, Cyclophosphamide, Bortezomib
  • Ulm, Germany
    University Hospital Ulm
May 26, 2022

Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Huntsville, Bethesda (Ublituximab,

Terminated
  • Non-Hodgkins Lymphoma
  • +6 more
  • Huntsville, Alabama
  • +1 more
May 5, 2022

Zanubrutinib in Waldenström's Macroglobulinemia (ARIADNE)

Recruiting
  • Waldenström's Macroglobulinemia
  • Salzburg, Austria
  • +1 more
May 2, 2022

Waldenström's Macroglobulinemia Trial in Busan (Lenalidomide, Bortezomib, Rituximab, Dexamethasone)

Recruiting
  • Waldenström's Macroglobulinemia
  • Lenalidomide, Bortezomib, Rituximab, Dexamethasone
  • Busan, Sue-gu, Korea, Republic of
    Kosin University Gospel Hospital
Mar 31, 2022

Questionnaire and Tissue Banking For Multiple Myeloma,

Active, not recruiting
  • Multiple Myeloma
  • +3 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Mar 15, 2022

    Waldenstrom's Macroglobulinemia Trial in Athens, Rotterdam, Salamanca (Bortezomib, Rituximab, Dexamethasone)

    Completed
    • Waldenstrom's Macroglobulinemia
    • Bortezomib, Rituximab, Dexamethasone
    • Athens, Attica, Greece
    • +3 more
    Apr 27, 2021

    Waldenstrom's Macroglobulinemia Trial in Boston (Everolimus, Rituximab, Bortezomib)

    Terminated
    Has Results
    • Waldenstrom's Macroglobulinemia
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Apr 22, 2021

    Waldenström's Macroglobulinemia Trial in Worldwide (Ibrutinib, Placebo, Rituximab)

    Completed
    Has Results
    • Waldenström's Macroglobulinemia
    • Los Angeles, California
    • +47 more
    Feb 9, 2021

    Waldenstrom's Macroglobulinemia Trial in Denver, Boston (LBH589)

    Completed
    Has Results
    • Waldenstrom's Macroglobulinemia
    • Denver, Colorado
    • +1 more
    Jan 10, 2021

    Waldenstrom's Macroglobulinemia Trial in Italy (Bortezomib-Rituximab-Bendamustine)

    Completed
    • Waldenstrom's Macroglobulinemia
    • Messina, ME, Italy
    • +22 more
    Dec 1, 2020

    Waldenstrom's Macroglobulinemia Trial in Boston (Bortezomib, Rituximab)

    Completed
    Has Results
    • Waldenstrom's Macroglobulinemia
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Oct 6, 2020

    Waldenstrom's Macroglobulinemia, Multiple Myeloma Trial in France, United States (Enzastaurin)

    Completed
    Has Results
    • Waldenstrom's Macroglobulinemia
    • Multiple Myeloma
    • Boston, Massachusetts
    • +3 more
    Sep 1, 2020

    Waldenstrom's Macroglobulinemia Trial in Boston (Ixazomib, Dexamethasone, Rituximab)

    Completed
    Has Results
    • Waldenstrom's Macroglobulinemia
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Aug 20, 2020

    Waldenstrom's Macroglobulinemia Trial in Palo Alto, Boston, New York (PCI-32765)

    Completed
    Has Results
    • Waldenstrom's Macroglobulinemia
    • Palo Alto, California
    • +3 more
    Jan 10, 2020

    Relapsed or Refractory Lymphoproliferative Malignancies, Hodgkin's Lymphoma, Peripheral T-cell Lymphoma Trial in United States

    Completed
    Has Results
    • Relapsed or Refractory Lymphoproliferative Malignancies
    • +4 more
    • Pralatrexate Injection
    • +3 more
    • Los Angeles, California
    • +14 more
    Dec 27, 2019

    Non-Hodgkins Lymphoma, B-cell Lymphoma, Waldenstrom's Macroglobulinemia Trial in United States (Ublituximab)

    Completed
    • Non-Hodgkins Lymphoma
    • +6 more
    • Huntsville, Alabama
    • +7 more
    Oct 1, 2019

    Waldenstrom's Macroglobulinemia Trial in United States (IMO-8400)

    Terminated
    Has Results
    • Waldenstrom's Macroglobulinemia
    • Fayetteville, Arkansas
    • +9 more
    Aug 28, 2019

    Influenza, Multiple Myeloma, Waldenstrom's Macroglobulinemia Trial in New Haven (Fluzone High Dose Vaccine, Standard of

    Completed
    Has Results
    • Influenza
    • +4 more
    • Fluzone High Dose Vaccine
    • Standard of care/Placebo
    • New Haven, Connecticut
      Yale University
    Jan 28, 2019

    Waldenstrom's Macroglobulinemia Trial in Boston (Dexamethasone, Carfilzomib, Rituximab)

    Completed
    Has Results
    • Waldenstrom's Macroglobulinemia
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Oct 26, 2018

    Waldenstrom's Macroglobulinemia Trial in Boston (RAD001)

    Completed
    Has Results
    • Waldenstrom's Macroglobulinemia
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Sep 6, 2018